Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

Hylton Nola M.; Gatsonis Constantine A.; Rosen Mark A.; Lehman Constance D.; Newitt David C.; Partridge Savannah C.; Bernreuter Wanda K.; Pisano Etta D.; Morris Elizabeth A.; Weatherall Paul T.; Polin Sandra M.; Newstead Gillian M.; Marques Helga S.; Esserman Laura J.; Schnall Mitchell D.

首页> 外文期刊>Radiology >Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

【24h】

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

机译：乳腺癌的新辅助化疗：MR影像显示的功能性肿瘤体积可预测ACRIN 6657 / CALGB 150007 I-SPY 1 TRIAL的无复发生存率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To evaluate volumetric magnetic resonance (MR) imaging for predicting recurrence-free survival (RFS) after neo-adjuvant chemotherapy (NACT) of breast cancer and to consider its predictive performance relative to pathologic complete response (PCR).

机译：目的：评价容积磁共振（MR）成像以预测乳腺癌新辅助化疗（NACT）后的无复发生存期（RFS），并考虑其相对于病理完全缓解（PCR）的预测性能。

著录项

来源
《Radiology》 |2016年第1期|共12页
作者
Hylton Nola M.; Gatsonis Constantine A.; Rosen Mark A.; Lehman Constance D.; Newitt David C.; Partridge Savannah C.; Bernreuter Wanda K.; Pisano Etta D.; Morris Elizabeth A.; Weatherall Paul T.; Polin Sandra M.; Newstead Gillian M.; Marques Helga S.; Esserman Laura J.; Schnall Mitchell D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL [J] . Hylton Nola M., Gatsonis Constantine A., Rosen Mark A., Radiology . 2016,第1期

机译：乳腺癌的新辅助化疗：MR影像显示的功能性肿瘤体积可预测ACRIN 6657 / CALGB 150007 I-SPY 1 TRIAL的无复发生存率
2. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). [J] . Laura J Esserman, Donald A Berry, Maggie C U Cheang, Breast cancer research and treatment. . 2012,第3期

机译：Neoadjuvant乳腺癌中的化疗反应和无复发存活取决于生物标志物轮廓：I-Spy 1试验结果（Calgb 150007/150012; acrin 6657）。
3. Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) [J] . Campbell Jeffrey I., Yau Christina, Krass Polina, Breast cancer research and treatment. . 2017,第1期

机译：Neoadjuvant化疗后乳腺癌癌症分期和病理完全反应的残余癌症负担比较：I-Spy 1试验结果（CalgB 150007/150012; acrin 6657）
4. Deformable image registration as a tool to improve survival prediction after neoadjuvant chemotherapy for breast cancer: Results from the ACRIN 6657/I-SPY-1 trial [C] . Nariman Jahani, Eric Cohen, Meng-Kang Hsieh, SPIE Medical Imaging Conference . 2018

机译：可变形图像配准作为改善乳腺癌新辅助化疗后生存预测的工具：ACRIN 6657 / I-SPY-1试验的结果
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL [O] . Nola M. Hylton, Constantine A. Gatsonis, Mark A. Rosen, -1

机译：乳腺癌的新辅助化疗：通过MR成像功能性肿瘤体积可预测无复发生存-ACRIN 6657 / CALGB 150007 I-SPY 1 TRIAL的结果
7. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL [O] . Nola M. Hylton, Constantine A. Gatsonis, Mark A. Rosen, 2016

机译：Neoadjuvant化疗乳腺癌：Mr Mr成像的功能性肿瘤量预测丙烯6657 / CalgB 150007 I-Spy 1试验的复发存活

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

摘要

著录项

相似文献

相关主题

期刊订阅